Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.07 +0.01 (+16.67%)
At close: Aug 20, 2026 · 4:00 PM EDT

Mosaic ImmunoEngineering (CPMV) Return on Sales (2010 - 2011)

Mosaic ImmunoEngineering (CPMV) posted quarterly Return on Sales of 0.07% for Q4 2011, up 14.0% year-over-year from 0.06% in Q4 2010, and down 180.47% quarter-over-quarter from 0.02% in Q3 2011.

Mosaic ImmunoEngineering (CPMV) Return on Sales (2010 - 2011) Analysis & Trends

Mosaic ImmunoEngineering's Return on Sales history runs 2 years deep, the most recent figure standing at 0.07% for Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 0.00%
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 0.00%
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 0.00%
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -0.05%
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 0.00%
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 0.00%
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 0.00%
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.00%
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 0.00%
10 Mosaic ImmunoEngineering 527,536.97 527,536.97 - -

Historic Data

Download Data
DateValue
Nov 30, 2011 -0.07%
Aug 31, 2011 -0.02%
Nov 30, 2010 -0.21%
Aug 31, 2010 -0.21%